Dystroglycan is associated with tumor progression and patient survival in gastric cancer

Pathology and Oncology Research

Volumn 18, Issue 1, 2012, Pages 79-84

  Shen, Jian Guo ^a   Xu, Chao Yang ^a   Li, Xin ^b   Dong, Ming Jun ^a   Jiang, Zi Nong ^a   Wang, Jin ^a   Wang, Lin Bo ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

dystroglycan; dystroglycan; Adhesion molecule; Gastric cancer; Prognosis

Indexed keywords

ALPHA DYSTROGLYCAN; BETA DYSTROGLYCAN;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MESENTERY METASTASIS; MESENTERY TUMOR; METASTASIS; OVARY METASTASIS; PANCREAS CANCER; PANCREAS METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STOMACH CANCER; STOMACH MUCOSA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

CHINA; DISEASE PROGRESSION; DYSTROGLYCANS; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84855262229     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9419-2     Document Type: Article

References (17)

1. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA Cancer J Clin 60 277 300 20610543 10.3322/caac.20073
2. J Masterson S O'Dea 2007 Posttranslational truncation of E-cadherin and significance for tumour progression Cells Tissues Organs 185 175 179 17587823 10.1159/000101318 1:CAS:528:DC%2BD2sXmvFSnu78%3D (Pubitemid 46956858)
3. A Sgambato A Brancaccio 2005 The dystroglycan complex: from biology to cancer J Cell Physiol 205 163 169 15920757 10.1002/jcp.20411 1:CAS:528:DC%2BD2MXhtFSrtLzM (Pubitemid 41428897)
4. MD Henry KP Campbell 1998 A role for dystroglycan in basement membrane assembly Cell 95 859 870 9865703 10.1016/S0092-8674(00)81708-0 1:CAS:528:DyaK1MXivVKk (Pubitemid 29014465)
5. O Ibraghimov-Beskrovnaya JM Ervasti CJ Leveille CA Slaughter SW Sernett KP Campbell 1992 Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix Nature 355 696 702 1741056 10.1038/355696a0 1:CAS:528:DyaK3sXitFSlu78%3D
6. PA Brennan J Jing M Ethunandan D Górecki 2004 Dystroglycan complex in cancer Eur J Surg Oncol 30 589 592 15256230 10.1016/j.ejso.2004.03.014 1:STN:280:DC%2BD2czltlemsw%3D%3D (Pubitemid 39060726)
7. MD Henry MB Cohen KP Campbell 2001 Reduced expression of dystroglycan in breast and prostate cancer Hum Pathol 32 791 795 11521221 10.1053/hupa.2001. 26468 1:CAS:528:DC%2BD3MXntVKnt7g%3D (Pubitemid 32803978)
8. A Sgambato M Migaldi M Montanari, et al. 2003 Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression Am J Pathol 162 849 860 12598319 10.1016/S0002-9440(10)63881-3 1:CAS:528:DC%2BD3sXit1GksL0%3D (Pubitemid 36237493)
9. A Sgambato E Tarquini F Resci, et al. 2006 Aberrant expression of alpha- dystroglycan in cervical and vulvar cancer Gynecol Oncol 103 397 404 16765426 10.1016/j.ygyno.2006.03.059 1:CAS:528:DC%2BD28XhtFegtbjN (Pubitemid 44740098)
10. SS Cross J Lippitt A Mitchell, et al. 2008 Expression of beta-dystroglycan is reduced or absent in many human carcinomas Histopathology 53 561 566 18983465 10.1111/j.1365-2559.2008.03157.x 1:STN:280: DC%2BD1cjhvVahsg%3D%3D
11. A Sgambato B De Paola M Migaldi, et al. 2007 Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells J Cell Physiol 213 528 39 17516554 10.1002/jcp.21130 1:CAS:528:DC%2BD2sXhtFKnu7jE (Pubitemid 47509736)
12. YW Moon SY Rha X Zhang, et al. 2009 Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer J Surg Oncol 100 459 465 19598149 10.1002/jso.21347
13. LZ Xu W Yang 1996 Immunohistochemistry results assessment China Oncol 6 229 231
14. J Schwock N Dhani DW Hedley 2010 Targeting focal adhesion kinase signaling in tumor growth and metastasis Expert Opin Ther Targets 14 77 94 20001212 10.1517/14728220903460340 1:CAS:528:DC%2BD1MXhsFCitbvM
15. A Sgambato A Camerini D Amoroso, et al. 2007 Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma Cancer Biol Ther 6 1840 1846 18087214 1:CAS:528:DC%2BD1cXks1Wjt7o%3D (Pubitemid 351590394)
16. C Losasso F Di Tommaso A Sgambato, et al. 2000 Anomalous dystroglycan in carcinoma cell lines FEBS Lett 484 194 198 11078877 10.1016/S0014-5793(00)02157- 8 1:CAS:528:DC%2BD3cXotVCktbY%3D
17. Jiang X, Rieder S, Giese NA, Friess H, Michalski CW, Kleeff J (2009) Reduced alpha-Dystroglycan Expression Correlates with Shortened Patient Survival in Pancreatic Cancer. J Surg Res [Epub ahead of print]